Abicipar (mono-DARPin anti-VEGF) Verified listing

You may also be interested in

LakeSai – Accelerating Discovery with AI You Can Trust

LakeSAI is a membership-based AI research agent built for scientists who need faster, deeper and more transparent access to biomedical knowledge. Users interact via natural language or structured data inputs, enabling precise, reproducible and evidence-based exploration.
Explore: https://lakesai.vitafluence.com

Marketed

A2AR positive allosteric modulator

Multiple, see therapeutic areas. GI indications also relevant.

Discovery

TOP-N53, TOP-V122 and TOP-M119

TOPADUR has discovered and developed new dual-acting drugs that target the cGMP-Enzyme Regulation System to stimulate microcirculation, enable tissue regeneration, and avoid local oxygen deficiency. Based on our key invention we have developed an attractive portfolio of drug candidates to treat aging-related diseases as chronic wounds, glaucoma, colorectal cancer, hair loss and skin aging.